GLP-1
Care Journal

The publication

The source record

Official pages, original research and clearly identified evidence limits.

Source notes

Source checks are dated individually below. Earlier material retains its original source history. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. FDA — creating and keeping a medication listPatient safety and medication records
  2. FDA — safely using sharps at home, work and while travelingSharps disposal safety
  3. NIA — questions for a medical checkupPatient communication
  4. NIA — talking with your doctor worksheetsAppointment preparation tools
  5. FDA — prescription medicine labeling FAQProduct document context
  6. FDA — compounding questions and answersRegulatory context
  7. FDA — unapproved GLP-1 drug concernsSafety information · Checked 2026-10-21
  8. CoreAge Rx — semaglutide offerProvider page
  9. CoreAge Rx — tirzepatide offerProvider page
  10. CoreAge Rx — pricing and plansProvider terms
  11. SuperHealthy Rx — current GLP-1 promotionProvider offer
  12. Likeness Rx — GLP-1 plan informationProvider offer and billing terms
  13. Ro — Body program and pricingProvider membership
  14. Noom Med — program pricingProvider offer; branded pathway reviewed
  15. Noom — branded-medication prescriptionsProvider pharmacy and follow-up process
  16. Found — plan offer termsProvider contract; branded plan reviewed
  17. It can be a lifesaving tool, especially during an emergencyPrimary health resource; checked October 5, 2026
  18. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossPrimary health resource; checked October 5, 2026
  19. FAQs | HersProvider public offer; checked October 5, 2026
  20. Frequently Asked Questions | LifeMD®Provider public offer; checked October 5, 2026
  21. Safely Using Sharps (Needles and Syringes)Federal patient information; checked October 5, 2026
  22. What Should I Ask My Doctor During a Checkup?Primary health resource; checked October 5, 2026
  23. Choosing a Safe & Successful Weight-loss Program - NIDDKPrimary health resource; checked October 5, 2026
  24. Weight Loss Care for Women, Built to Last | HersProvider public offer; checked October 5, 2026
  25. Online weight loss medication with or without insuranceProvider public offer; checked October 5, 2026
  26. Calibrate Weight Loss Pricing: How Much Does Calibrate Cost? | CalibrateProvider public offer; checked October 5, 2026
  27. Weight Management Program Overview | LifeMD®Provider public offer; checked October 5, 2026
  28. Programs & Membership Plans | LifeMD®️Provider public offer; checked October 5, 2026
  29. Bare Lúx Studio: Medical weight-loss serviceProvider public information; checked October 15, 2026
  30. Bare Lúx Studio: Consultation deposit and practice overviewProvider public information; checked October 15, 2026
  31. Bare Lúx Studio: Team and older booking FAQProvider public information; checked October 15, 2026
  32. Bare Lúx Studio: Booking, payment and refund terms; April 29, 2026Provider public information; checked October 15, 2026
  33. FDA: Concerns with unapproved GLP-1 drugs used for weight lossMedication safety context; checked October 15, 2026
  34. Pacific Northwest Medical Group: Submitted voucher landing pageProvider public information; checked October 15, 2026
  35. PNW voucher page: Linked privacy and website termsProvider public information; checked October 15, 2026
  36. Pacific Northwest Medical Group: Current clinic overviewProvider public information; checked October 15, 2026
  37. PNW Medical Group: October 2026 pricing and autopay conditionsProvider public information; checked October 15, 2026
  38. PNW Medical Group: Medication and follow-up programProvider public information; checked October 15, 2026
  39. PNW Medical Group: Puyallup and Federal Way clinicsProvider public information; checked October 15, 2026
  40. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.Indexed original research abstract · Checked 2026-10-21
  41. FDA approves treatment for serious liver disease known as MASHOfficial FDA page read through web tool; historical approval announcement, not complete current labeling · Checked 2026-10-21
  42. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.Primary research or official information · Checked 2026-10-21
  43. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.Primary research or official information · Checked 2026-10-21
  44. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.Indexed original research abstract · Checked 2026-10-21
  45. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.Indexed original research abstract · Checked 2026-10-21
  46. DailyMed - FOUNDAYO- orforglipron tablet, film coatedOfficial page retrieved in full · Checked 2026-10-21
  47. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.Primary research or official information · Checked 2026-10-21
  48. Sesame GLP-1 programProvider description · Checked 2026-11-20